Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank

(2018) Nicholas J Thomas et al.   Lancet Diabetes & Endocrinology

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody–Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

(2018) Anita L. Grubb et al.   DIABETES CARE

2. Classification and Diagnosis of Diabetes

(2016)   DIABETES CARE

Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic

(2016) S. V. Hope et al.   DIABETIC MEDICINE

Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes

(2016) Georgina M. Williams et al.   DIABETOLOGIA

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

(2015) Richard A. Oram et al.   DIABETES CARE

Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature

(2015) Beverley M Shields et al.   BMJ Open

The clinical utility of C-peptide measurement in the care of patients with diabetes

(2013) A. G. Jones et al.   DIABETIC MEDICINE

Clinical Applications of Diabetes Antibody Testing

(2009) Polly J. Bingley   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM